- Cytochrome P450 2C19 Polymorphism is Associated with Reduced Clopidogrel Response in Cerebrovascular Disease
-
Lee JB, Lee KA, Lee KY
- KMID: 1108064
- Yonsei Med J.
- 2011 Sep;52(5):734-738.
- doi: 10.3349/ymj.2011.52.5.734
PURPOSE: Clopidogrel is a prodrug that requires transformation into an active metabolite by cytochrome P450 (CYP) in the liver in order to irreversibly inhibit the P2Y12 adenosine diphosphate platelet receptor.... -
- CITED
-
- Close
- SHARE
-
- Close
